Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study to Test How Different Doses of BI 3814916 Are Tolerated by Healthy People
Sponsor: Boehringer Ingelheim
Summary
The main objectives of this trial are to investigate safety, tolerability and pharmacokinetics (PK) of BI 3814916 in healthy male and female trial participants.
Official title: A Phase 1, Randomised, Single-blind, Placebo-controlled Trial to Assess Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses of BI 3814916 in Healthy Male and Female Subjects
Key Details
Gender
All
Age Range
18 Years - 65 Years
Study Type
INTERVENTIONAL
Enrollment
136
Start Date
2026-05-18
Completion Date
2027-07-12
Last Updated
2026-04-02
Healthy Volunteers
Yes
Conditions
Interventions
BI 3814916
BI 3814916
Placebo matching BI 3814916
Placebo matching BI 3814916
Locations (1)
SGS Life Science Services - Clinical Research
Edegem, Belgium